Buy ($175)
Topics covered: Volatility reduction, Underperforming funds, The valuation of biotech names, Sector-focused growth management investment style, Risk-adjusted p/e ratio, Risk Management, Near-term performance, Mutual funds, Management of client expectations, Individual security selection, ETFs, Company growth rate, Classifying funds based on risk, Asset Allocation, Alpha generation
or create an account with a social network.
or login using a social network
